Alaunos Therapeutics, Inc. Derivative Liability, Fair Value, Gross Liability
Alaunos Therapeutics, Inc. (TCRT) had Derivative Liability, Fair Value, Gross Liability of $0 as of 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Notes
us-gaap:DerivativeFairValueOfDerivativeLiability · last filed 2021-03-01
- 2020-12-31: Derivative Liability, Fair Value, Gross Liability $0.00.
- 2019-12-31: Derivative Liability, Fair Value, Gross Liability $0.00.
- 2018-12-31: Derivative Liability, Fair Value, Gross Liability $0.00.
- 2018-09-30: Derivative Liability, Fair Value, Gross Liability $2.60M.
| Period end | Derivative Liability, Fair Value, Gross Liability |
|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 |
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 |
| 2018-12-31 | $0.00 10-K · filed 2021-03-01 |
| 2018-09-30 | $2.60M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $2.36M 10-Q · filed 2018-11-09 |
| 2018-03-31 | $2.47M 10-Q · filed 2018-11-09 |
| 2017-12-31 | $2.42M 10-K · filed 2021-03-01 |
| 2017-09-30 | $2.35M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $2.48M 10-Q · filed 2017-11-06 |
| 2017-03-31 | $2.47M 10-Q · filed 2017-07-31 |
| 2016-12-31 | $862.00K 10-K · filed 2020-03-02 |
| 2016-09-30 | $694.00K 10-Q · filed 2016-11-09 |
| 2016-07-01 | $694.00K 10-Q · filed 2016-11-09 |
| 2016-06-30 | $694.00K 10-K · filed 2019-03-05 |
| 2015-12-31 | $694.00K 10-K · filed 2017-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |